cardiac arrhythmia due to therapeutic clozapine use
AI-generated summary
Edmund James Fern, aged 30, died at a psychiatric institution (James Nash House) on 4 September 1997, nine days after septoplasty for nasal obstruction. He was on multiple medications including clozapine 350mg nightly, chloral hydrate 1000mg, amitriptyline 50mg, and post-operatively received Panadeine Forte and cephalexin. Clinical staff noted he appeared sedated upon return from hospital. The cause of death was cardiac arrhythmia due to therapeutic clozapine use, not airway obstruction as initially suspected. Key clinical lessons: excessive polypharmacy with multiple sedating drugs that interact (clozapine, chloral hydrate, clonazepam, amitriptyline) created cumulative sedative and cardiac effects; clozapine levels were elevated due to recent smoking cessation; no regular medication review or reduction despite multiple overlapping drug effects; inadequate discharge planning post-operatively with no specific care instructions; and failure to consider drug interactions when prescribing post-operative analgesics. The case demonstrates need for rigorous medication review, awareness of clozapine-induced arrhythmia risk, especially with heavy sedation, and proper discharge communication.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
polypharmacy with multiple interacting sedative medications
elevated clozapine levels due to smoking cessation in July 1997
heavy sedation from combination of clozapine, chloral hydrate, amitriptyline, benzodiazepines and post-operative analgesics
recent septoplasty surgery with post-operative medications added to existing complex regimen
lack of medication review and optimization
inadequate discharge planning from hospital with no specific post-operative care instructions
overlapping anticholinergic effects from multiple medications
Coroner's recommendations
The Medical Board of South Australia should take urgent steps to remind the medical profession about the dangers of polypharmacy, their responsibilities for monitoring and continual re-evaluation of prescribed medications, and the need to form independent judgment about the appropriateness of prescribing without relying solely on previous actions of other doctors
General practitioners in particular should be reminded that medications they prescribe may have additive and/or potentiating effects upon other medications the patient may be taking, and that certain medications may accumulate to toxic and lethal levels unless regular monitoring and re-evaluation is carried out
A copy of the findings should be forwarded to the Adverse Drug Reactions Advisory Committee of the Therapeutic Goods Administration
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.